Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...
Discover a practical blueprint for building a modern, intelligence-driven threat program aligned with enterprise risk and ...
There are thousands of students like me who are juggling jobs, classes, food insecurity, and now a shutdown that threatens to ...
Twelve patients achieved stable disease, whereof five with disease control lasting over six months; this correlates with strong CD4? and CD8? memory T-cell expansionAs previously reported, the single ...
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at ...
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of safety and early ...
From tumor profiling to CAR-T optimization, AI is accelerating discovery and decision-making in immuno-oncology. PICI researchers are leveraging multimodal data and large language models to predict ...
Your daughter aced her freshman biology class and came home announcing she wants to be a biomedical engineer. Meanwhile, your ...
The oral medication, enlicitide, lowered LDL cholesterol by up to 60% and could eventually offer an option for people whose ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Air Canada today announced the opening of its fourth Air Canada Café, bringing the premium grab-and-go concept to Vancouver ...
AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON") and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics ("Cyncado") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback